1. Home
  2. NOTV vs IXHL Comparison

NOTV vs IXHL Comparison

Compare NOTV & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.67

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.42

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
IXHL
Founded
1974
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
49.1M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NOTV
IXHL
Price
$0.67
$0.42
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.6M
24.9M
Earning Date
02-04-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$513,024,000.00
$12,000.00
Revenue This Year
$6.26
N/A
Revenue Next Year
$45.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.54
N/A
52 Week Low
$0.66
$0.08
52 Week High
$6.48
$2.25

Technical Indicators

Market Signals
Indicator
NOTV
IXHL
Relative Strength Index (RSI) 30.65 52.82
Support Level $0.79 $0.38
Resistance Level $0.86 $0.45
Average True Range (ATR) 0.07 0.04
MACD -0.00 0.00
Stochastic Oscillator 6.69 47.53

Price Performance

Historical Comparison
NOTV
IXHL

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: